RNA Delivery & LNP Formulation Scientist

GenScript Biotech Corp.; Redmond (WA); On-site; USD 75,000 - 90,000; Full time

Benefits offered by this job

Medical Insurance

Vision Insurance

Dental Insurance

401(k) Plan

Paid Time Off

Parental Leave

Onsite Gym

Job summary

GenScript Biotech Corporation in the United States is seeking a Research Associate to join the RNA team, focusing on developing novel lipid nanoparticle formulations for RNA delivery and advancing RNA product research.

The role involves preparing formulations, performing characterization assays, analyzing data, and contributing to method development and technical reports. A Bachelor's degree in a related field and hands-on experience in lipid nanoparticles are preferred.

Qualifications

• Bachelor's degree in a related field; Master preferred.
• 0–5 years' nucleic acid delivery experience.
• Hands-on lipid nanoparticle formulation and characterization.
• Experience with RNA analytics (ribogreen, gels, capillary).

Responsibilities

• Prepare formulations and perform characterization assays.
• Support developing assays for formulation characterization in vitro.
• Contribute in the development, writing and reviewing analytical method protocols.
• Prepare technical reports and presentations of findings.
• Maintain clean and organized work areas.

Skills

Lipid nanoparticle formulation

RNA analytics

Data analysis

Team collaboration

Education

Bachelor's degree in molecular biology or related field

Master's degree preferred

Tools

RiboGreen assay

Gel electrophoresis

Capillary electrophoresis

Job description

GenScript Biotech Corporation in the United States is seeking a Research Associate to join the RNA team, focusing on developing novel lipid nanoparticle formulations for RNA delivery and advancing RNA product research.

The role involves preparing formulations, performing characterization assays, analyzing data, and contributing to method development and technical reports. A Bachelor's degree in a related field and hands-on experience in lipid nanoparticles are preferred.